Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cisplatin or ImmunoTHerapy in Association With Definitive Radiotherapy in HPV-related oropharyngEal Squamous Cell Carcinoma: a Randomized Phase II Trial.

NCT03623646 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT03623646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03623646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cisplatin or ImmunoTHerapy in Association With Definitive Radiotherapy in HPV-related oropharyngEal Squamous Cell Carcinoma: a Randomized Phase II Trial.
Lead sponsor
Institut Claudius Regaud
Phase
Phase 2
Overall status
Completed
Start date
March 15, 2019
Completion date
February 14, 2023
Enrollment
11 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

oropharyngeal squamous cell carcinoma